Annual EBIT
-$188.42 M
-$109.91 M-139.99%
31 December 2023
Summary:
NovoCure Limited annual earnings before interest & taxes is currently -$188.42 million, with the most recent change of -$109.91 million (-139.99%) on 31 December 2023. During the last 3 years, it has fallen by -$224.10 million (-628.03%). NVCR annual EBIT is now -628.03% below its all-time high of $44.83 million.NVCR EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$32.09 M
+$1.49 M+4.43%
30 September 2024
Summary:
NovoCure Limited quarterly earnings before interest & taxes is currently -$32.09 million, with the most recent change of +$1.49 million (+4.43%) on 30 September 2024. Over the past year, it has increased by +$26.15 million (+44.90%). NVCR quarterly EBIT is now -284.70% below its all-time high of $17.38 million, reached on 31 December 2020.NVCR Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$114.46 M
+$26.15 M+18.60%
30 September 2024
Summary:
NovoCure Limited TTM earnings before interest & taxes is currently -$114.46 million, with the most recent change of +$26.15 million (+18.60%) on 30 September 2024. Over the past year, it has increased by +$98.66 million (+46.29%). NVCR TTM EBIT is now -393.66% below its all-time high of $38.98 million, reached on 31 March 2021.NVCR TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NVCR EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -140.0% | +44.9% | +46.3% |
| 3 y3 years | -628.0% | -275.3% | -3115.1% |
| 5 y5 years | -480.6% | -932.5% | -1245.0% |
NVCR EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -628.0% | at low | -3881.6% | +48.8% | -3115.1% | +46.3% |
| 5 y | 5 years | -628.0% | at low | -284.7% | +48.8% | -393.7% | +46.3% |
| alltime | all time | -628.0% | at low | -284.7% | +48.8% | -393.7% | +46.3% |
NovoCure Limited EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$32.09 M(-4.4%) | -$114.46 M(-18.6%) |
| June 2024 | - | -$33.58 M(-19.1%) | -$140.61 M(-17.1%) |
| Mar 2024 | - | -$41.52 M(+471.3%) | -$169.69 M(-9.9%) |
| Dec 2023 | -$188.42 M(+140.0%) | -$7.27 M(-87.5%) | -$188.42 M(-11.6%) |
| Sept 2023 | - | -$58.24 M(-7.0%) | -$213.12 M(+18.7%) |
| June 2023 | - | -$62.66 M(+4.0%) | -$179.49 M(+30.1%) |
| Mar 2023 | - | -$60.25 M(+88.5%) | -$137.96 M(+75.7%) |
| Dec 2022 | -$78.51 M(+61.4%) | -$31.97 M(+29.9%) | -$78.51 M(+5.7%) |
| Sept 2022 | - | -$24.61 M(+16.5%) | -$74.25 M(+27.6%) |
| June 2022 | - | -$21.13 M(+2521.3%) | -$58.19 M(+17.9%) |
| Mar 2022 | - | -$806.00 K(-97.1%) | -$49.35 M(+1.5%) |
| Dec 2021 | -$48.63 M(-236.3%) | -$27.70 M(+223.9%) | -$48.63 M(+1266.2%) |
| Sept 2021 | - | -$8.55 M(-30.4%) | -$3.56 M(-117.8%) |
| June 2021 | - | -$12.29 M(>+9900.0%) | $20.01 M(-48.7%) |
| Mar 2021 | - | -$88.00 K(-100.5%) | $38.98 M(+9.2%) |
| Dec 2020 | $35.68 M(+606.6%) | $17.38 M(+15.7%) | $35.68 M(+46.1%) |
| Sept 2020 | - | $15.02 M(+125.3%) | $24.43 M(+84.2%) |
| June 2020 | - | $6.67 M(-297.2%) | $13.26 M(+70.3%) |
| Mar 2020 | - | -$3.38 M(-155.3%) | $7.79 M(+54.2%) |
| Dec 2019 | $5.05 M | $6.12 M(+58.7%) | $5.05 M(-159.3%) |
| Sept 2019 | - | $3.85 M(+222.3%) | -$8.51 M(-51.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2019 | - | $1.20 M(-119.5%) | -$17.61 M(-32.0%) |
| Mar 2019 | - | -$6.12 M(-17.8%) | -$25.89 M(-20.2%) |
| Dec 2018 | -$32.45 M(-15.1%) | -$7.44 M(+41.9%) | -$32.45 M(+14.2%) |
| Sept 2018 | - | -$5.25 M(-26.0%) | -$28.42 M(-2.3%) |
| June 2018 | - | -$7.08 M(-44.1%) | -$29.09 M(-22.5%) |
| Mar 2018 | - | -$12.68 M(+271.3%) | -$37.54 M(-1.8%) |
| Dec 2017 | -$38.24 M(-66.9%) | -$3.41 M(-42.3%) | -$38.24 M(-27.7%) |
| Sept 2017 | - | -$5.92 M(-61.9%) | -$52.91 M(-29.7%) |
| June 2017 | - | -$15.53 M(+16.1%) | -$75.25 M(-22.4%) |
| Mar 2017 | - | -$13.37 M(-26.1%) | -$96.96 M(-16.1%) |
| Dec 2016 | -$115.53 M(+10.3%) | -$18.09 M(-36.0%) | -$115.53 M(-10.3%) |
| Sept 2016 | - | -$28.27 M(-24.1%) | -$128.82 M(+3.2%) |
| June 2016 | - | -$37.24 M(+16.6%) | -$124.80 M(+8.7%) |
| Mar 2016 | - | -$31.94 M(+1.8%) | -$114.77 M(+9.5%) |
| Dec 2015 | -$104.77 M(+30.5%) | -$31.38 M(+29.5%) | -$104.77 M(+8.6%) |
| Sept 2015 | - | -$24.24 M(-10.9%) | -$96.50 M(+7.0%) |
| June 2015 | - | -$27.21 M(+24.0%) | -$90.17 M(+43.2%) |
| Mar 2015 | - | -$21.95 M(-5.0%) | -$62.96 M(+53.5%) |
| Dec 2014 | -$80.26 M(+14.9%) | -$23.11 M(+29.1%) | -$41.02 M(+129.1%) |
| Sept 2014 | - | -$17.91 M | -$17.91 M |
| Dec 2013 | -$69.86 M | - | - |
FAQ
- What is NovoCure Limited annual earnings before interest & taxes?
- What is the all time high annual EBIT for NovoCure Limited?
- What is NovoCure Limited annual EBIT year-on-year change?
- What is NovoCure Limited quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for NovoCure Limited?
- What is NovoCure Limited quarterly EBIT year-on-year change?
- What is NovoCure Limited TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for NovoCure Limited?
- What is NovoCure Limited TTM EBIT year-on-year change?
What is NovoCure Limited annual earnings before interest & taxes?
The current annual EBIT of NVCR is -$188.42 M
What is the all time high annual EBIT for NovoCure Limited?
NovoCure Limited all-time high annual earnings before interest & taxes is $44.83 M
What is NovoCure Limited annual EBIT year-on-year change?
Over the past year, NVCR annual earnings before interest & taxes has changed by -$109.91 M (-139.99%)
What is NovoCure Limited quarterly earnings before interest & taxes?
The current quarterly EBIT of NVCR is -$32.09 M
What is the all time high quarterly EBIT for NovoCure Limited?
NovoCure Limited all-time high quarterly earnings before interest & taxes is $17.38 M
What is NovoCure Limited quarterly EBIT year-on-year change?
Over the past year, NVCR quarterly earnings before interest & taxes has changed by +$26.15 M (+44.90%)
What is NovoCure Limited TTM earnings before interest & taxes?
The current TTM EBIT of NVCR is -$114.46 M
What is the all time high TTM EBIT for NovoCure Limited?
NovoCure Limited all-time high TTM earnings before interest & taxes is $38.98 M
What is NovoCure Limited TTM EBIT year-on-year change?
Over the past year, NVCR TTM earnings before interest & taxes has changed by +$98.66 M (+46.29%)